Crude homogenates of the nematode worm Caenorhabditis elegans were shown to bind the cholinergic antagonists [3H]N-methylscopolamine and quinuclidinyl benzilate ([3H]QNB) with high affinity. The dissociation constant for [3H]N-methylscopolamine binding determined from equilibrium saturation experiments (KD = 3.7 x 10-l' M) was in good agreement with that determined from forward and reverse rate constants (KD = k&k,, = 5 x 10-l' M). These binding sites were blocked stereospecifically by the (+) enantiomer of the muscarinic antagonist benzetimide, as would be expected of true muscarinic receptors. Furthermore, competition experiments with unlabeled cholinergic agonists and antagonists indicate that C3H]QNB and [3H]N-methylscopolamine bind to the same sites in nematode homogenates and that these sites are similar but not identical to muscarinic receptors in vertebrates. The concentration of [3H]Z'V-methylscopolamine and [3H]QNB binding sites in adult populations of wild-type nematodes was approximately 10 fmol/mg of protein. This was approximately 4-fold lower than the concentration of binding sites in young (Ll and L2 stage) juveniles. These stage-specific differences in binding site concentrations parallel differences in acetylcholinesterase activity in larval and adult nematodes (Culotti, J., G. von Ehrenstein, M. R. Culotti, and R. L. Russell (1981
No takes yet. Share an insight, caveat, or question.
Culotti et al. (1983) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: